Finally, while our study characterizes two distinct cNF developmental stages (progression and stabilization), their analysis likely focused on mature, stabilized tumors, as most cNFs in NF1 patients are quiescent with minimal MAPK pathway activity [9]. This evidence concerns the gene NPHS1 and neurofibromatosis type 1.